HomeBALPHARMA • NSE
add
Bal Pharma Ltd
Previous close
₹121.52
Day range
₹118.01 - ₹124.95
Year range
₹81.20 - ₹132.45
Market cap
1.90B INR
Avg Volume
52.98K
P/E ratio
25.87
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 946.26M | 14.77% |
Operating expense | 334.23M | 36.78% |
Net income | 54.73M | 242.00% |
Net profit margin | 5.78 | 197.94% |
Earnings per share | — | — |
EBITDA | 99.55M | 9.46% |
Effective tax rate | 3.81% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 200.49M | 168.66% |
Total assets | 3.20B | 2.30% |
Total liabilities | 2.51B | 0.66% |
Total equity | 692.61M | — |
Shares outstanding | 14.67M | — |
Price to book | 2.57 | — |
Return on assets | — | — |
Return on capital | 9.00% | — |
Cash Flow
Net change in cash
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 54.73M | 242.00% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1987
Website
Employees
869